Women Health Diagnostics Market Segmentation, Forecast, Market Analysis, Global Industry Size and Share to 2025

The Global Women Health Diagnostics Market is a significant growth at a CAGR of 7.4% during the forecast period. The female bodysurfers from certain allergy, diseases, disorders, infections, anemia, and cancers such as autoimmune disease, renal disease, cardiovascular disease, and thyroid disease. There is a number of cancer cases that are contributing to the increased use of gynecological surgical devices for the treatment of cancer and gynecological problems. The main types of cancer that commonly affect women’s health include cervical cancer, breast cancer, and ovarian cancer. In the female population, breast cancer is the most common form of cancer occurring across the globe. The factors of breast cancer that propel market growth include the lack of physical exercise, alcohol consumption, genetic history, menopausal changes, and exposure to ionizing radiation.

Browse the full report description Global Women Health Diagnostics Market Size, Share & Trends Analysis Report by Application (Breast Cancer Testing, Cervical Cancer Testing, Pregnancy & Fertility Testing, Ovarian Cancer Testing, Infectious Disease Testing, Ultrasound Tests, Sexually Transmitted Disease Testing, and Others) and by End-User (Diagnostic and Imaging Centers, Hospitals and Clinics, and Home Care) and Forecast 2019-2025 at https://www.omrglobal.com/industry-reports/womens-health-diagnostics-market-size

There are various therapies, treatments, and medications that are used to reduce the risk of cancer such as hormone therapy drugs that are enabled to treat breast cancer. Moreover, tamoxifen and raloxifene have been used for the prevention of breast cancer. The hormone receptor (HR) positive breast cancers are those that contain estrogen receptor (ER) and progesterone receptor (PR) due to this cancer grow in response to these hormones and can be treated with hormone therapies. The inhibitors also play a prominent role in breast cancer such as aromatase inhibitors that consist of exemestane and anastrozole. Due to changing levels of ovarian hormones, it makes less estrogen such inhibitors have been used.

Breast tissue consists of the main components of ducts, fatty & fibrous connective tissue, and lobules. According to Cleveland Clinic Organization, 5% of breast cancer cases occur in women under 40 years of age and diagnosing breast cancer in younger women is more difficult than older women, as the breast tissue is generally denser in young women than the breast tissues found in older women. According to the World Health Organization (WHO), breast cancer is the most frequent cancer that affects nearly 2.1 million women each year across the globe. In 2018, the mortality rate due to breast cancer reached about 627,000; which covers nearly 15% of all cancer deaths among women.

According to Breast Cancer Organization, in January 2019, there are more than 3.1 million women suffers from breast cancer in the US. The mortality rate of breast cancer is higher than any other cancer such as skin cancer, lung cancer, and prostate cancer. In 2019, it is estimated that about 30% of newly diagnosed cancers in women will be breast cancers. In 2019, the American Cancer Society estimates for breast cancer in the US for 2019 that about 268,600 new cases of invasive breast cancer will be diagnosed in women and about 41,760 women will lose their lives from breast cancer.

Global Women Health Diagnostics Market- Segmentation

By Application
• Breast Cancer Testing
• Cervical Cancer Testing
• Pregnancy & Fertility Testing
• Ovarian Cancer Testing
• Infectious Disease Testing
• Ultrasound Tests
• Sexually Transmitted Disease Testing
• Others
By End-User
• Diagnostic and Imaging Centers
• Hospitals and Clinics
• Home Care

Global Women Health Diagnostics Market– Segment by Region

North America
• The US
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle-East & Africa

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/womens-health-diagnostics-market-size

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +1 646-755-7667, +91 780-304-0404

Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.